Rank | Gene Set | Z-score |
---|---|---|
1 | proteasome assembly (GO:0043248) | 7.11957558 |
2 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 6.51724139 |
3 | antigen processing and presentation via MHC class Ib (GO:0002475) | 6.34006868 |
4 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.45328842 |
5 | mitotic nuclear envelope reassembly (GO:0007084) | 5.28935573 |
6 | nuclear envelope reassembly (GO:0031468) | 5.28935573 |
7 | ribosomal small subunit assembly (GO:0000028) | 4.92445607 |
8 | peptidyl-lysine dimethylation (GO:0018027) | 4.83028108 |
9 | negative regulation of catenin import into nucleus (GO:0035414) | 4.43385504 |
10 | ribosomal small subunit biogenesis (GO:0042274) | 4.33345782 |
11 | platelet dense granule organization (GO:0060155) | 3.87785432 |
12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.80211845 |
13 | proline biosynthetic process (GO:0006561) | 3.70794268 |
14 | rRNA modification (GO:0000154) | 3.60212126 |
15 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.53795162 |
16 | rRNA methylation (GO:0031167) | 3.50397898 |
17 | ribosome biogenesis (GO:0042254) | 3.41798784 |
18 | ribosomal large subunit biogenesis (GO:0042273) | 3.39588603 |
19 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.37243753 |
20 | presynaptic membrane assembly (GO:0097105) | 3.35682140 |
21 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.32285942 |
22 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.32134491 |
23 | cotranslational protein targeting to membrane (GO:0006613) | 3.25926542 |
24 | ribosome assembly (GO:0042255) | 3.24680427 |
25 | viral transcription (GO:0019083) | 3.23885067 |
26 | protein targeting to ER (GO:0045047) | 3.23705775 |
27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.21395233 |
28 | L-phenylalanine catabolic process (GO:0006559) | 3.21395233 |
29 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.20070104 |
30 | regulation of sister chromatid cohesion (GO:0007063) | 3.18968927 |
31 | determination of adult lifespan (GO:0008340) | 3.17855732 |
32 | translational termination (GO:0006415) | 3.17815527 |
33 | establishment of integrated proviral latency (GO:0075713) | 3.15338107 |
34 | positive regulation of chromosome segregation (GO:0051984) | 3.11425357 |
35 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.10974265 |
36 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.10289529 |
37 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.09993512 |
38 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.09993512 |
39 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.09993512 |
40 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.06004664 |
41 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.04191496 |
42 | negative regulation of ligase activity (GO:0051352) | 3.04191496 |
43 | opsonization (GO:0008228) | 3.03708378 |
44 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.01682722 |
45 | termination of RNA polymerase III transcription (GO:0006386) | 3.01682722 |
46 | protein localization to endoplasmic reticulum (GO:0070972) | 3.00043479 |
47 | translational elongation (GO:0006414) | 2.94357095 |
48 | cellular component biogenesis (GO:0044085) | 2.93822132 |
49 | mitotic nuclear envelope disassembly (GO:0007077) | 2.92817706 |
50 | aromatic amino acid family catabolic process (GO:0009074) | 2.92287155 |
51 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.91325600 |
52 | negative regulation of granulocyte differentiation (GO:0030853) | 2.90774887 |
53 | translational initiation (GO:0006413) | 2.89765098 |
54 | positive regulation of protein kinase C signaling (GO:0090037) | 2.89502556 |
55 | positive regulation of antigen processing and presentation (GO:0002579) | 2.82566662 |
56 | translation (GO:0006412) | 2.81167340 |
57 | protein prenylation (GO:0018342) | 2.79906757 |
58 | prenylation (GO:0097354) | 2.79906757 |
59 | L-phenylalanine metabolic process (GO:0006558) | 2.77860150 |
60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.77860150 |
61 | fatty acid elongation (GO:0030497) | 2.77587990 |
62 | multi-organism intracellular transport (GO:1902583) | 2.76883943 |
63 | transport of virus (GO:0046794) | 2.76883943 |
64 | intracellular transport of virus (GO:0075733) | 2.76883943 |
65 | multi-organism transport (GO:0044766) | 2.76883943 |
66 | multi-organism localization (GO:1902579) | 2.76883943 |
67 | presynaptic membrane organization (GO:0097090) | 2.76881191 |
68 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.75863473 |
69 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.75394068 |
70 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.75394068 |
71 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.75394068 |
72 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.74252403 |
73 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.73363707 |
74 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.73363707 |
75 | indole-containing compound catabolic process (GO:0042436) | 2.73348432 |
76 | indolalkylamine catabolic process (GO:0046218) | 2.73348432 |
77 | tryptophan catabolic process (GO:0006569) | 2.73348432 |
78 | maturation of SSU-rRNA (GO:0030490) | 2.72550923 |
79 | regulation of activation of Janus kinase activity (GO:0010533) | 2.72505336 |
80 | positive regulation of protein export from nucleus (GO:0046827) | 2.72211217 |
81 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 2.70312646 |
82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.69360761 |
83 | coenzyme catabolic process (GO:0009109) | 2.68284453 |
84 | chromatin remodeling at centromere (GO:0031055) | 2.67843223 |
85 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.67665021 |
86 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.67665021 |
87 | neuron remodeling (GO:0016322) | 2.66577129 |
88 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.65385455 |
89 | proline metabolic process (GO:0006560) | 2.65119888 |
90 | CENP-A containing nucleosome assembly (GO:0034080) | 2.64321930 |
91 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.64139380 |
92 | regulation of catenin import into nucleus (GO:0035412) | 2.63389785 |
93 | nuclear envelope disassembly (GO:0051081) | 2.63325904 |
94 | membrane disassembly (GO:0030397) | 2.63325904 |
95 | mitotic metaphase plate congression (GO:0007080) | 2.62926987 |
96 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.62662694 |
97 | superoxide anion generation (GO:0042554) | 2.61776081 |
98 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.60827043 |
99 | central nervous system myelination (GO:0022010) | 2.60797542 |
100 | axon ensheathment in central nervous system (GO:0032291) | 2.60797542 |
101 | tryptophan metabolic process (GO:0006568) | 2.59672708 |
102 | nucleotide transmembrane transport (GO:1901679) | 2.57538629 |
103 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.56829987 |
104 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.56829987 |
105 | neuron cell-cell adhesion (GO:0007158) | 2.56762356 |
106 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.56594731 |
107 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.56594731 |
108 | tRNA aminoacylation for protein translation (GO:0006418) | 2.56121739 |
109 | paraxial mesoderm development (GO:0048339) | 2.56018108 |
110 | respiratory electron transport chain (GO:0022904) | 2.54949283 |
111 | cellular response to interferon-beta (GO:0035458) | 2.54837351 |
112 | formation of translation preinitiation complex (GO:0001731) | 2.54776595 |
113 | cellular biogenic amine catabolic process (GO:0042402) | 2.54584533 |
114 | amine catabolic process (GO:0009310) | 2.54584533 |
115 | mitotic spindle checkpoint (GO:0071174) | 2.53985331 |
116 | amino acid activation (GO:0043038) | 2.53297132 |
117 | tRNA aminoacylation (GO:0043039) | 2.53297132 |
118 | spindle checkpoint (GO:0031577) | 2.52101205 |
119 | negative regulation of chromosome segregation (GO:0051985) | 2.51891995 |
120 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.51860401 |
121 | negative regulation of sister chromatid segregation (GO:0033046) | 2.51860401 |
122 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.51860401 |
123 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.51860401 |
124 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.51860401 |
125 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.50769154 |
126 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.50042468 |
127 | positive regulation of ligase activity (GO:0051351) | 2.49804102 |
128 | regulation of sister chromatid segregation (GO:0033045) | 2.49722588 |
129 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.49722588 |
130 | cofactor catabolic process (GO:0051187) | 2.48858996 |
131 | opioid receptor signaling pathway (GO:0038003) | 2.48198138 |
132 | blood coagulation, intrinsic pathway (GO:0007597) | 2.47075629 |
133 | electron transport chain (GO:0022900) | 2.46750030 |
134 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.46027658 |
135 | ATP synthesis coupled proton transport (GO:0015986) | 2.46027658 |
136 | positive regulation of action potential (GO:0045760) | 2.44934745 |
137 | NAD biosynthetic process (GO:0009435) | 2.40167009 |
138 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.37981109 |
139 | T-helper 1 type immune response (GO:0042088) | 2.37827777 |
140 | aldehyde catabolic process (GO:0046185) | 2.37681197 |
141 | indolalkylamine metabolic process (GO:0006586) | 2.36340808 |
142 | intracellular pH reduction (GO:0051452) | 2.34976028 |
143 | response to interferon-beta (GO:0035456) | 2.33934076 |
144 | polyketide metabolic process (GO:0030638) | 2.32229584 |
145 | doxorubicin metabolic process (GO:0044598) | 2.32229584 |
146 | daunorubicin metabolic process (GO:0044597) | 2.32229584 |
147 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.31920010 |
148 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.31737458 |
149 | alkaloid metabolic process (GO:0009820) | 2.29356784 |
150 | adenosine metabolic process (GO:0046085) | 2.27909429 |
151 | limb bud formation (GO:0060174) | 2.27565668 |
152 | respiratory chain complex IV assembly (GO:0008535) | 2.23715680 |
153 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.23121237 |
154 | bile acid biosynthetic process (GO:0006699) | 2.21995053 |
155 | cellular ketone body metabolic process (GO:0046950) | 2.20214889 |
156 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.18653121 |
157 | kynurenine metabolic process (GO:0070189) | 2.17780361 |
158 | glycerophospholipid catabolic process (GO:0046475) | 2.17522009 |
159 | regulation of interleukin-8 secretion (GO:2000482) | 2.16659955 |
160 | postsynaptic membrane organization (GO:0001941) | 2.16328759 |
161 | dopamine transport (GO:0015872) | 2.14956857 |
162 | positive regulation of acute inflammatory response (GO:0002675) | 2.14685636 |
163 | regulation of memory T cell differentiation (GO:0043380) | 2.14544107 |
164 | regulation of fibrinolysis (GO:0051917) | 2.14249189 |
165 | import into cell (GO:0098657) | 2.13629406 |
166 | tyrosine metabolic process (GO:0006570) | 2.12836792 |
167 | respiratory burst (GO:0045730) | 2.11030345 |
168 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.10247391 |
169 | regulation of cholesterol esterification (GO:0010872) | 2.09137723 |
170 | low-density lipoprotein particle remodeling (GO:0034374) | 2.08563887 |
171 | aromatic amino acid family metabolic process (GO:0009072) | 2.08166021 |
172 | regulation of triglyceride catabolic process (GO:0010896) | 2.07794776 |
173 | short-term memory (GO:0007614) | 2.07443753 |
174 | lymphoid progenitor cell differentiation (GO:0002320) | 2.07323656 |
175 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.07254977 |
176 | phospholipid efflux (GO:0033700) | 2.05511638 |
177 | negative regulation of lipase activity (GO:0060192) | 2.05307629 |
178 | glyoxylate metabolic process (GO:0046487) | 2.03767078 |
179 | dopamine biosynthetic process (GO:0042416) | 2.02630882 |
180 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.02351655 |
181 | DNA strand renaturation (GO:0000733) | 10.0921149 |
182 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.99943737 |
183 | protein carboxylation (GO:0018214) | 1.99943737 |
184 | fibrinolysis (GO:0042730) | 1.99724253 |
185 | high-density lipoprotein particle remodeling (GO:0034375) | 1.97386189 |
186 | negative regulation of protein localization to cell surface (GO:2000009) | 1.95490522 |
187 | behavioral response to nicotine (GO:0035095) | 1.95409985 |
188 | righting reflex (GO:0060013) | 1.94810057 |
189 | negative regulation of neurotransmitter transport (GO:0051589) | 1.94674380 |
190 | cholesterol efflux (GO:0033344) | 1.94397580 |
191 | cellular response to exogenous dsRNA (GO:0071360) | 1.94285153 |
192 | pH reduction (GO:0045851) | 1.93856846 |
193 | uronic acid metabolic process (GO:0006063) | 1.92943800 |
194 | glucuronate metabolic process (GO:0019585) | 1.92943800 |
195 | plasma lipoprotein particle remodeling (GO:0034369) | 1.92901009 |
196 | protein-lipid complex remodeling (GO:0034368) | 1.92901009 |
197 | macromolecular complex remodeling (GO:0034367) | 1.92901009 |
198 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 1.92213002 |
199 | very long-chain fatty acid metabolic process (GO:0000038) | 1.90616949 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.46189497 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.25612786 |
3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.23718815 |
4 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.93203297 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.17396346 |
6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.17069458 |
7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.95000137 |
8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.87365616 |
9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.85970689 |
10 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.85334321 |
11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.76813329 |
12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.73148965 |
13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.70751930 |
14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.69978595 |
15 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.61387055 |
16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.57535615 |
17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.54757511 |
18 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.54545288 |
19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.51060724 |
20 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.46341839 |
21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.44841640 |
22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.40266436 |
23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.39972827 |
24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.38639823 |
25 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.17289138 |
26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.12293238 |
27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10434522 |
28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08732707 |
29 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.06714693 |
30 | VDR_22108803_ChIP-Seq_LS180_Human | 2.05865104 |
31 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.04351463 |
32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.02988408 |
33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.99419721 |
34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98971718 |
35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.98573447 |
36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.94556162 |
37 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.94380926 |
38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.92781913 |
39 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.91980207 |
40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.91467389 |
41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.88986059 |
42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85865497 |
43 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.85695153 |
44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.85661269 |
45 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.84662449 |
46 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.84200507 |
47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84024199 |
48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.83829511 |
49 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.80877847 |
50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.79824375 |
51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.78896563 |
52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77728421 |
53 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.76951828 |
54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.76885172 |
55 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.73143779 |
56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72143265 |
57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.70627449 |
58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.69764724 |
59 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.69403803 |
60 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.68832280 |
61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67651134 |
62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.66191987 |
63 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.65965092 |
64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.65200791 |
65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.64982057 |
66 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.64326914 |
67 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.63011245 |
68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.62975650 |
69 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.61871688 |
70 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.61817541 |
71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.61487069 |
72 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60344563 |
73 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.60316570 |
74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.60100915 |
75 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59731262 |
76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.59718165 |
77 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.59494978 |
78 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.59217420 |
79 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.58463890 |
80 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.58378835 |
81 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.58031848 |
82 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.56642769 |
83 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56356804 |
84 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.55652441 |
85 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.55124900 |
86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.53790255 |
87 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.52770271 |
88 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.52770271 |
89 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.52770271 |
90 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.52456185 |
91 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.52456185 |
92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.52329654 |
93 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.51719807 |
94 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51676375 |
95 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.50460111 |
96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48664635 |
97 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.47483166 |
98 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.47131346 |
99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44908460 |
100 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.44451073 |
101 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.43623242 |
102 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.42730759 |
103 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.41685394 |
104 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.40188566 |
105 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.39238562 |
106 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.39188150 |
107 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38528924 |
108 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.37938107 |
109 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.37284071 |
110 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37009950 |
111 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.36790085 |
112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.35871860 |
113 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.35655252 |
114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.34706882 |
115 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.34114295 |
116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34006016 |
117 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.33877957 |
118 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.32501756 |
119 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.32442835 |
120 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31903699 |
121 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30089744 |
122 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29807256 |
123 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.29712144 |
124 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.29703412 |
125 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28666870 |
126 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28663388 |
127 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.27229497 |
128 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.26909058 |
129 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25216897 |
130 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.24750585 |
131 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24663398 |
132 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.23851965 |
133 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22873983 |
134 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.22853093 |
135 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22139222 |
136 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.21873070 |
137 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21793916 |
138 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21464209 |
139 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20611010 |
140 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.20514573 |
141 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.19244082 |
142 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.18500904 |
143 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17328358 |
144 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.17272473 |
145 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.16970205 |
146 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.16645206 |
147 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15441061 |
148 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14856027 |
149 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14556643 |
150 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14424568 |
151 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14028662 |
152 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13957755 |
153 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.13384379 |
154 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13107448 |
155 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.12640637 |
156 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.12190231 |
157 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11938501 |
158 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.11276861 |
159 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11256054 |
160 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.10477986 |
161 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10293030 |
162 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09962654 |
163 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09962654 |
164 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.09397926 |
165 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.09293295 |
166 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.08659787 |
167 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08357773 |
168 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07097536 |
169 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.06905052 |
170 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06764964 |
171 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06077329 |
172 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06036230 |
173 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05877535 |
174 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05500061 |
175 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03938500 |
176 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98770753 |
177 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92117982 |
178 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90978967 |
179 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.90581208 |
180 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.90579833 |
181 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88731083 |
182 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88552228 |
183 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.88542586 |
184 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.88463978 |
185 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.85443369 |
186 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.85269126 |
187 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.84797514 |
188 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.83883044 |
189 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.79674026 |
190 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.79378920 |
191 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.79335545 |
192 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.79139555 |
193 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.77822302 |
194 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.76854997 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003878_abnormal_ear_physiology | 3.73419842 |
2 | MP0005377_hearing/vestibular/ear_phenot | 3.73419842 |
3 | MP0008438_abnormal_cutaneous_collagen | 3.53352045 |
4 | MP0003724_increased_susceptibility_to | 3.41888836 |
5 | MP0003111_abnormal_nucleus_morphology | 3.16109236 |
6 | MP0003941_abnormal_skin_development | 3.05104611 |
7 | MP0003880_abnormal_central_pattern | 2.96995173 |
8 | MP0003693_abnormal_embryo_hatching | 2.86183281 |
9 | MP0002139_abnormal_hepatobiliary_system | 2.83594588 |
10 | MP0004272_abnormal_basement_membrane | 2.81924335 |
11 | MP0004957_abnormal_blastocyst_morpholog | 2.79555724 |
12 | MP0010030_abnormal_orbit_morphology | 2.75309260 |
13 | MP0005408_hypopigmentation | 2.52578653 |
14 | MP0005085_abnormal_gallbladder_physiolo | 2.41934763 |
15 | MP0002938_white_spotting | 2.36739404 |
16 | MP0005379_endocrine/exocrine_gland_phen | 2.33505098 |
17 | MP0005360_urolithiasis | 2.22774446 |
18 | MP0000372_irregular_coat_pigmentation | 2.21819368 |
19 | MP0003950_abnormal_plasma_membrane | 2.17747416 |
20 | MP0008932_abnormal_embryonic_tissue | 2.17152193 |
21 | MP0003937_abnormal_limbs/digits/tail_de | 2.14505558 |
22 | MP0005257_abnormal_intraocular_pressure | 2.10545695 |
23 | MP0003195_calcinosis | 2.07386875 |
24 | MP0005365_abnormal_bile_salt | 2.01186646 |
25 | MP0001835_abnormal_antigen_presentation | 1.99209494 |
26 | MP0004381_abnormal_hair_follicle | 1.96663134 |
27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.95906397 |
28 | MP0003136_yellow_coat_color | 1.95315481 |
29 | MP0001346_abnormal_lacrimal_gland | 1.94791844 |
30 | MP0006276_abnormal_autonomic_nervous | 1.93264180 |
31 | MP0002148_abnormal_hypersensitivity_rea | 1.92601654 |
32 | MP0003718_maternal_effect | 1.87644346 |
33 | MP0002876_abnormal_thyroid_physiology | 1.83764886 |
34 | MP0010368_abnormal_lymphatic_system | 1.79241873 |
35 | MP0000566_synostosis | 1.76903565 |
36 | MP0003077_abnormal_cell_cycle | 1.75862637 |
37 | MP0005451_abnormal_body_composition | 1.71615254 |
38 | MP0004142_abnormal_muscle_tone | 1.70553335 |
39 | MP0009785_altered_susceptibility_to | 1.69858064 |
40 | MP0002163_abnormal_gland_morphology | 1.69743708 |
41 | MP0001188_hyperpigmentation | 1.65845939 |
42 | MP0005409_darkened_coat_color | 1.65340657 |
43 | MP0010094_abnormal_chromosome_stability | 1.63957322 |
44 | MP0004742_abnormal_vestibular_system | 1.63170136 |
45 | MP0000350_abnormal_cell_proliferation | 1.59209269 |
46 | MP0001905_abnormal_dopamine_level | 1.57193110 |
47 | MP0003890_abnormal_embryonic-extraembry | 1.56037195 |
48 | MP0002102_abnormal_ear_morphology | 1.54470015 |
49 | MP0002166_altered_tumor_susceptibility | 1.54294472 |
50 | MP0002277_abnormal_respiratory_mucosa | 1.53782741 |
51 | MP0001529_abnormal_vocalization | 1.51278055 |
52 | MP0002837_dystrophic_cardiac_calcinosis | 1.50477696 |
53 | MP0008058_abnormal_DNA_repair | 1.49532230 |
54 | MP0001986_abnormal_taste_sensitivity | 1.48744429 |
55 | MP0009250_abnormal_appendicular_skeleto | 1.47893311 |
56 | MP0002006_tumorigenesis | 1.43225627 |
57 | MP0001293_anophthalmia | 1.40861520 |
58 | MP0001730_embryonic_growth_arrest | 1.40779775 |
59 | MP0009379_abnormal_foot_pigmentation | 1.39574846 |
60 | MP0002638_abnormal_pupillary_reflex | 1.37788428 |
61 | MP0005671_abnormal_response_to | 1.36149340 |
62 | MP0001790_abnormal_immune_system | 1.34656776 |
63 | MP0005387_immune_system_phenotype | 1.34656776 |
64 | MP0005551_abnormal_eye_electrophysiolog | 1.34600241 |
65 | MP0002419_abnormal_innate_immunity | 1.32378222 |
66 | MP0005000_abnormal_immune_tolerance | 1.32179153 |
67 | MP0001486_abnormal_startle_reflex | 1.31282829 |
68 | MP0003123_paternal_imprinting | 1.30777733 |
69 | MP0006082_CNS_inflammation | 1.27214210 |
70 | MP0010352_gastrointestinal_tract_polyps | 1.26997508 |
71 | MP0009764_decreased_sensitivity_to | 1.26282401 |
72 | MP0001501_abnormal_sleep_pattern | 1.26281814 |
73 | MP0000920_abnormal_myelination | 1.25808188 |
74 | MP0003315_abnormal_perineum_morphology | 1.23211145 |
75 | MP0008004_abnormal_stomach_pH | 1.22277283 |
76 | MP0002085_abnormal_embryonic_tissue | 1.21895082 |
77 | MP0003690_abnormal_glial_cell | 1.21735731 |
78 | MP0010386_abnormal_urinary_bladder | 1.21460488 |
79 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19914180 |
80 | MP0009745_abnormal_behavioral_response | 1.19652210 |
81 | MP0003868_abnormal_feces_composition | 1.19482082 |
82 | MP0005535_abnormal_body_temperature | 1.19145958 |
83 | MP0005197_abnormal_uvea_morphology | 1.18379379 |
84 | MP0005025_abnormal_response_to | 1.18333740 |
85 | MP0002697_abnormal_eye_size | 1.15283143 |
86 | MP0010329_abnormal_lipoprotein_level | 1.14492591 |
87 | MP0000762_abnormal_tongue_morphology | 1.14077296 |
88 | MP0005275_abnormal_skin_tensile | 1.13911081 |
89 | MP0001440_abnormal_grooming_behavior | 1.13277593 |
90 | MP0001672_abnormal_embryogenesis/_devel | 1.13163791 |
91 | MP0005380_embryogenesis_phenotype | 1.13163791 |
92 | MP0003122_maternal_imprinting | 1.11779035 |
93 | MP0009046_muscle_twitch | 1.11238533 |
94 | MP0002064_seizures | 1.11153630 |
95 | MP0005423_abnormal_somatic_nervous | 1.11105332 |
96 | MP0001984_abnormal_olfaction | 1.11042894 |
97 | MP0002084_abnormal_developmental_patter | 1.10794846 |
98 | MP0003436_decreased_susceptibility_to | 1.10490726 |
99 | MP0002254_reproductive_system_inflammat | 1.09576450 |
100 | MP0002272_abnormal_nervous_system | 1.09059895 |
101 | MP0004134_abnormal_chest_morphology | 1.08344216 |
102 | MP0002086_abnormal_extraembryonic_tissu | 1.07990183 |
103 | MP0002736_abnormal_nociception_after | 1.07125394 |
104 | MP0009384_cardiac_valve_regurgitation | 1.07067072 |
105 | MP0005083_abnormal_biliary_tract | 1.06344858 |
106 | MP0001661_extended_life_span | 1.05924486 |
107 | MP0002088_abnormal_embryonic_growth/wei | 1.05326882 |
108 | MP0001968_abnormal_touch/_nociception | 1.05321937 |
109 | MP0001697_abnormal_embryo_size | 1.05168853 |
110 | MP0001286_abnormal_eye_development | 1.04438437 |
111 | MP0005645_abnormal_hypothalamus_physiol | 1.03866763 |
112 | MP0003984_embryonic_growth_retardation | 1.03266038 |
113 | MP0004019_abnormal_vitamin_homeostasis | 1.02428708 |
114 | MP0003566_abnormal_cell_adhesion | 1.02274895 |
115 | MP0008007_abnormal_cellular_replicative | 1.02176026 |
116 | MP0001666_abnormal_nutrient_absorption | 1.02052994 |
117 | MP0006292_abnormal_olfactory_placode | 1.00873481 |
118 | MP0005646_abnormal_pituitary_gland | 1.00726121 |
119 | MP0002067_abnormal_sensory_capabilities | 1.00612768 |
120 | MP0004510_myositis | 1.00129305 |
121 | MP0009672_abnormal_birth_weight | 0.99992575 |
122 | MP0003942_abnormal_urinary_system | 0.98941579 |
123 | MP0000358_abnormal_cell_content/ | 0.98558699 |
124 | MP0005332_abnormal_amino_acid | 0.97031272 |
125 | MP0003806_abnormal_nucleotide_metabolis | 0.96816562 |
126 | MP0005171_absent_coat_pigmentation | 0.93675260 |
127 | MP0002971_abnormal_brown_adipose | 0.93166516 |
128 | MP0006054_spinal_hemorrhage | 0.91826583 |
129 | MP0005595_abnormal_vascular_smooth | 0.91784694 |
130 | MP0008469_abnormal_protein_level | 0.90799717 |
131 | MP0005164_abnormal_response_to | 0.90661051 |
132 | MP0003191_abnormal_cellular_cholesterol | 0.89815041 |
133 | MP0002080_prenatal_lethality | 0.89168338 |
134 | MP0009697_abnormal_copulation | 0.88906374 |
135 | MP0010307_abnormal_tumor_latency | 0.88378246 |
136 | MP0001764_abnormal_homeostasis | 0.88045160 |
137 | MP0003011_delayed_dark_adaptation | 0.88037911 |
138 | MP0002735_abnormal_chemical_nociception | 0.88007965 |
139 | MP0002118_abnormal_lipid_homeostasis | 0.87757895 |
140 | MP0002723_abnormal_immune_serum | 0.87476472 |
141 | MP0002751_abnormal_autonomic_nervous | 0.86476869 |
142 | MP0005670_abnormal_white_adipose | 0.86318483 |
143 | MP0008057_abnormal_DNA_replication | 0.84261729 |
144 | MP0005084_abnormal_gallbladder_morpholo | 0.83698606 |
145 | MP0002572_abnormal_emotion/affect_behav | 0.83555719 |
146 | MP0005464_abnormal_platelet_physiology | 0.83328605 |
147 | MP0001324_abnormal_eye_pigmentation | 0.83034109 |
148 | MP0003186_abnormal_redox_activity | 0.82837770 |
149 | MP0002233_abnormal_nose_morphology | 0.82761762 |
150 | MP0004782_abnormal_surfactant_physiolog | 0.82550801 |
151 | MP0001800_abnormal_humoral_immune | 0.82470231 |
152 | MP0000015_abnormal_ear_pigmentation | 0.81594225 |
153 | MP0005389_reproductive_system_phenotype | 0.81379086 |
154 | MP0002933_joint_inflammation | 0.81323226 |
155 | MP0003705_abnormal_hypodermis_morpholog | 0.81312636 |
156 | MP0002295_abnormal_pulmonary_circulatio | 0.81275467 |
157 | MP0001119_abnormal_female_reproductive | 0.81183920 |
158 | MP0005174_abnormal_tail_pigmentation | 0.80818387 |
159 | MP0009763_increased_sensitivity_to | 0.79522447 |
160 | MP0005248_abnormal_Harderian_gland | 0.78613603 |
161 | MP0000026_abnormal_inner_ear | 0.78309894 |
162 | MP0002452_abnormal_antigen_presenting | 0.76461949 |
163 | MP0004233_abnormal_muscle_weight | 0.76428590 |
164 | MP0003879_abnormal_hair_cell | 0.76241018 |
165 | MP0003283_abnormal_digestive_organ | 0.76194305 |
166 | MP0005165_increased_susceptibility_to | 0.75291173 |
167 | MP0008874_decreased_physiological_sensi | 0.74797453 |
168 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74633738 |
169 | MP0000579_abnormal_nail_morphology | 0.74223893 |
170 | MP0001533_abnormal_skeleton_physiology | 0.73821702 |
171 | MP0002060_abnormal_skin_morphology | 0.73644094 |
172 | MP0001915_intracranial_hemorrhage | 0.71463379 |
173 | MP0002210_abnormal_sex_determination | 0.70799150 |
174 | MP0005623_abnormal_meninges_morphology | 0.70414819 |
175 | MP0000432_abnormal_head_morphology | 0.69991001 |
176 | MP0003755_abnormal_palate_morphology | 0.69143636 |
177 | MP0001919_abnormal_reproductive_system | 0.68240502 |
178 | MP0003935_abnormal_craniofacial_develop | 0.67841653 |
179 | MP0002160_abnormal_reproductive_system | 0.67032795 |
180 | MP0005023_abnormal_wound_healing | 0.64523322 |
181 | MP0001299_abnormal_eye_distance/ | 0.64508841 |
182 | MP0000647_abnormal_sebaceous_gland | 0.62616324 |
183 | MP0005075_abnormal_melanosome_morpholog | 0.62245374 |
184 | MP0000627_abnormal_mammary_gland | 0.62231123 |
185 | MP0001881_abnormal_mammary_gland | 0.61616428 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Chronic otitis media (HP:0000389) | 6.15305715 |
2 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.63779565 |
3 | Muscle fiber atrophy (HP:0100295) | 4.34364614 |
4 | Achilles tendon contracture (HP:0001771) | 4.26434397 |
5 | Shawl scrotum (HP:0000049) | 4.19066948 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 4.15657244 |
7 | Large eyes (HP:0001090) | 4.12814089 |
8 | Abnormality of the Achilles tendon (HP:0005109) | 4.08438913 |
9 | Trismus (HP:0000211) | 4.06164881 |
10 | Esophageal atresia (HP:0002032) | 3.98374500 |
11 | Flat capital femoral epiphysis (HP:0003370) | 3.82730400 |
12 | Nasal polyposis (HP:0100582) | 3.71256070 |
13 | Large for gestational age (HP:0001520) | 3.62576537 |
14 | Chronic sinusitis (HP:0011109) | 3.56715107 |
15 | Acute necrotizing encephalopathy (HP:0006965) | 3.55041504 |
16 | Elbow flexion contracture (HP:0002987) | 3.50293948 |
17 | Parakeratosis (HP:0001036) | 3.33905454 |
18 | Joint hemorrhage (HP:0005261) | 3.16626891 |
19 | Reticulocytopenia (HP:0001896) | 3.14940559 |
20 | Overlapping toe (HP:0001845) | 3.13980322 |
21 | Acute encephalopathy (HP:0006846) | 3.11616032 |
22 | Progressive macrocephaly (HP:0004481) | 3.07144427 |
23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.06715228 |
24 | Abnormality of the nasal mucosa (HP:0000433) | 3.06423087 |
25 | Chronic hepatic failure (HP:0100626) | 3.03632083 |
26 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.02927614 |
27 | Abnormal number of erythroid precursors (HP:0012131) | 3.01215403 |
28 | Septo-optic dysplasia (HP:0100842) | 2.99089435 |
29 | Respiratory difficulties (HP:0002880) | 2.93975409 |
30 | Mitochondrial inheritance (HP:0001427) | 2.93859084 |
31 | Renal Fanconi syndrome (HP:0001994) | 2.86040438 |
32 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.85670537 |
33 | Cerebral edema (HP:0002181) | 2.83550840 |
34 | Hypothermia (HP:0002045) | 2.79817723 |
35 | Rib fusion (HP:0000902) | 2.79361458 |
36 | Gastrointestinal atresia (HP:0002589) | 2.77679010 |
37 | Increased IgM level (HP:0003496) | 2.76371684 |
38 | Sparse eyelashes (HP:0000653) | 2.72040911 |
39 | Premature rupture of membranes (HP:0001788) | 2.69234143 |
40 | Type I transferrin isoform profile (HP:0003642) | 2.68890469 |
41 | Atrioventricular block (HP:0001678) | 2.67531688 |
42 | Hypoglycemic seizures (HP:0002173) | 2.66214377 |
43 | Hyperlipoproteinemia (HP:0010980) | 2.65252416 |
44 | Focal motor seizures (HP:0011153) | 2.64451498 |
45 | Absent/shortened dynein arms (HP:0200106) | 2.60063768 |
46 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.60063768 |
47 | Midline defect of the nose (HP:0004122) | 2.59044088 |
48 | Optic disc pallor (HP:0000543) | 2.56863318 |
49 | Beaking of vertebral bodies (HP:0004568) | 2.54883786 |
50 | Hepatocellular necrosis (HP:0001404) | 2.53065923 |
51 | 3-Methylglutaconic aciduria (HP:0003535) | 2.42801604 |
52 | Hepatic necrosis (HP:0002605) | 2.42350091 |
53 | Renal cortical cysts (HP:0000803) | 2.39745563 |
54 | Increased CSF lactate (HP:0002490) | 2.35582012 |
55 | Increased hepatocellular lipid droplets (HP:0006565) | 2.34657006 |
56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32340341 |
57 | Large earlobe (HP:0009748) | 2.32267461 |
58 | Flexion contracture of toe (HP:0005830) | 2.30039732 |
59 | Joint contractures involving the joints of the feet (HP:0100492) | 2.30039732 |
60 | Lipid accumulation in hepatocytes (HP:0006561) | 2.27492664 |
61 | Bile duct proliferation (HP:0001408) | 2.27251549 |
62 | Abnormal biliary tract physiology (HP:0012439) | 2.27251549 |
63 | Proximal placement of thumb (HP:0009623) | 2.26453817 |
64 | Abnormality of renal resorption (HP:0011038) | 2.26348479 |
65 | Intrahepatic cholestasis (HP:0001406) | 2.23789017 |
66 | Decreased central vision (HP:0007663) | 2.21986445 |
67 | Deviation of the thumb (HP:0009603) | 2.21216396 |
68 | Macrocytic anemia (HP:0001972) | 2.20937270 |
69 | Prolonged neonatal jaundice (HP:0006579) | 2.20719903 |
70 | Hypophosphatemic rickets (HP:0004912) | 2.20176679 |
71 | Hyperventilation (HP:0002883) | 2.19401182 |
72 | Hypoglycemic coma (HP:0001325) | 2.17281127 |
73 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.17137114 |
74 | Purpura (HP:0000979) | 2.16994075 |
75 | Pulmonary artery stenosis (HP:0004415) | 2.16276658 |
76 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.14703419 |
77 | Ectopia lentis (HP:0001083) | 2.12629304 |
78 | Thyroid-stimulating hormone excess (HP:0002925) | 2.10589913 |
79 | Abnormality of methionine metabolism (HP:0010901) | 2.09567205 |
80 | Protrusio acetabuli (HP:0003179) | 2.09422728 |
81 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.08487939 |
82 | Abnormality of secondary sexual hair (HP:0009888) | 2.07301014 |
83 | Abnormality of the axillary hair (HP:0100134) | 2.07301014 |
84 | Basal ganglia calcification (HP:0002135) | 2.06424160 |
85 | Abnormal pupillary function (HP:0007686) | 2.05975913 |
86 | Enlarged kidneys (HP:0000105) | 2.05678179 |
87 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.05342309 |
88 | Febrile seizures (HP:0002373) | 2.05060391 |
89 | Recurrent bronchitis (HP:0002837) | 2.03773403 |
90 | Increased intramyocellular lipid droplets (HP:0012240) | 2.03615274 |
91 | Wide intermamillary distance (HP:0006610) | 2.03424713 |
92 | Long toe (HP:0010511) | 2.03410970 |
93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02847953 |
94 | Osteomalacia (HP:0002749) | 2.02105382 |
95 | Wide nose (HP:0000445) | 2.01652601 |
96 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.98675096 |
97 | Vascular calcification (HP:0004934) | 1.97711973 |
98 | Hypoplastic pelvis (HP:0008839) | 1.96076485 |
99 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.95464607 |
100 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.95464607 |
101 | Abnormal protein glycosylation (HP:0012346) | 1.95464607 |
102 | Abnormal glycosylation (HP:0012345) | 1.95464607 |
103 | Progressive inability to walk (HP:0002505) | 1.95108257 |
104 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.94954711 |
105 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.94303155 |
106 | Gingival bleeding (HP:0000225) | 1.94121480 |
107 | Progressive muscle weakness (HP:0003323) | 1.93826627 |
108 | Abnormal ciliary motility (HP:0012262) | 1.92692386 |
109 | Lactic acidosis (HP:0003128) | 1.92274488 |
110 | Clubbing of toes (HP:0100760) | 1.91324285 |
111 | Abnormality of the renal cortex (HP:0011035) | 1.87696013 |
112 | Increased muscle lipid content (HP:0009058) | 1.87357078 |
113 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.86946243 |
114 | Fair hair (HP:0002286) | 1.83961351 |
115 | Increased serum pyruvate (HP:0003542) | 1.83246554 |
116 | Abnormality of glycolysis (HP:0004366) | 1.83246554 |
117 | Menorrhagia (HP:0000132) | 1.82960876 |
118 | Symptomatic seizures (HP:0011145) | 1.82849385 |
119 | Trigonocephaly (HP:0000243) | 1.81988057 |
120 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.81978495 |
121 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.81976530 |
122 | Amyloidosis (HP:0011034) | 1.81628700 |
123 | Colon cancer (HP:0003003) | 1.81178183 |
124 | Glycosuria (HP:0003076) | 1.79599508 |
125 | Abnormality of urine glucose concentration (HP:0011016) | 1.79599508 |
126 | Reduced antithrombin III activity (HP:0001976) | 1.79101104 |
127 | Congenital stationary night blindness (HP:0007642) | 1.78809136 |
128 | Recurrent bacterial skin infections (HP:0005406) | 1.78759066 |
129 | Conjugated hyperbilirubinemia (HP:0002908) | 1.78574286 |
130 | Absent septum pellucidum (HP:0001331) | 1.78543546 |
131 | Optic nerve hypoplasia (HP:0000609) | 1.77735795 |
132 | Deep venous thrombosis (HP:0002625) | 1.77565711 |
133 | Ankle contracture (HP:0006466) | 1.77511671 |
134 | Vacuolated lymphocytes (HP:0001922) | 1.76993510 |
135 | Glomerulonephritis (HP:0000099) | 1.76697735 |
136 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.76037028 |
137 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.76037028 |
138 | Xanthomatosis (HP:0000991) | 1.75709749 |
139 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.75437176 |
140 | Abnormal lung lobation (HP:0002101) | 1.74600156 |
141 | Conical tooth (HP:0000698) | 1.73175170 |
142 | True hermaphroditism (HP:0010459) | 1.73026257 |
143 | Patchy hypopigmentation of hair (HP:0011365) | 1.72684488 |
144 | Arachnodactyly (HP:0001166) | 1.72074203 |
145 | Microvesicular hepatic steatosis (HP:0001414) | 1.71964969 |
146 | Increased corneal curvature (HP:0100692) | 1.71719827 |
147 | Keratoconus (HP:0000563) | 1.71719827 |
148 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.71550478 |
149 | Hypobetalipoproteinemia (HP:0003563) | 1.70370607 |
150 | Recurrent skin infections (HP:0001581) | 1.68942603 |
151 | White forelock (HP:0002211) | 1.68370011 |
152 | Lethargy (HP:0001254) | 1.67747666 |
153 | Cardiovascular calcification (HP:0011915) | 1.67284767 |
154 | Deep philtrum (HP:0002002) | 1.67277559 |
155 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.67101269 |
156 | Exercise intolerance (HP:0003546) | 1.66383328 |
157 | Dry hair (HP:0011359) | 1.65651064 |
158 | Recurrent abscess formation (HP:0002722) | 1.65564596 |
159 | Spontaneous abortion (HP:0005268) | 1.65262452 |
160 | Short middle phalanx of the 5th finger (HP:0004220) | 1.64822840 |
161 | Systemic lupus erythematosus (HP:0002725) | 1.64789892 |
162 | Abnormality of incisor morphology (HP:0011063) | 1.64752242 |
163 | Self-mutilation (HP:0000742) | 1.64527088 |
164 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.64033625 |
165 | Leukodystrophy (HP:0002415) | 1.63804812 |
166 | Respiratory failure (HP:0002878) | 1.63121418 |
167 | Bifid tongue (HP:0010297) | 1.63095090 |
168 | Blepharitis (HP:0000498) | 1.62879918 |
169 | Meckel diverticulum (HP:0002245) | 1.62099468 |
170 | Partial agenesis of the corpus callosum (HP:0001338) | 1.61083351 |
171 | Abolished electroretinogram (ERG) (HP:0000550) | 1.60362083 |
172 | X-linked dominant inheritance (HP:0001423) | 1.59812474 |
173 | Upper limb muscle weakness (HP:0003484) | 1.59792640 |
174 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.59710953 |
175 | Preauricular skin tag (HP:0000384) | 1.57957384 |
176 | Absent epiphyses (HP:0010577) | 1.57366119 |
177 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.57366119 |
178 | Arthrogryposis multiplex congenita (HP:0002804) | 1.56847705 |
179 | Abnormality of the ileum (HP:0001549) | 1.56740574 |
180 | Abnormality of the fingertips (HP:0001211) | 1.53797565 |
181 | Abnormality of dentin (HP:0010299) | 1.53515022 |
182 | Patellar aplasia (HP:0006443) | 1.52265367 |
183 | Prominent nose (HP:0000448) | 1.51954010 |
184 | Gout (HP:0001997) | 1.51444785 |
185 | Bifid uvula (HP:0000193) | 1.50689922 |
186 | Abnormality of macular pigmentation (HP:0008002) | 1.49462527 |
187 | Chromsome breakage (HP:0040012) | 1.47664792 |
188 | Camptodactyly of toe (HP:0001836) | 1.47012638 |
189 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.46967171 |
190 | Flat face (HP:0012368) | 1.46799860 |
191 | Adactyly (HP:0009776) | 1.46698650 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TGFBR2 | 4.33914937 |
2 | CASK | 4.26532936 |
3 | MOS | 3.78271763 |
4 | TNIK | 3.24573180 |
5 | STK10 | 2.89216830 |
6 | BUB1 | 2.73517772 |
7 | STK16 | 2.59927628 |
8 | PTK2 | 2.58801196 |
9 | PBK | 2.52422812 |
10 | NME2 | 2.40981197 |
11 | IRAK3 | 2.35845051 |
12 | BLK | 2.35232614 |
13 | IRAK4 | 2.22526318 |
14 | TAOK2 | 2.19998485 |
15 | GRK7 | 2.11190513 |
16 | MUSK | 2.07423373 |
17 | RIPK4 | 2.03148329 |
18 | INSRR | 2.00486850 |
19 | TTK | 1.98311388 |
20 | ADRBK2 | 1.93486644 |
21 | MAP3K14 | 1.89164793 |
22 | VRK2 | 1.88381004 |
23 | EIF2AK1 | 1.83406900 |
24 | PDK2 | 1.81176686 |
25 | ZAK | 1.77272262 |
26 | SRPK1 | 1.75836924 |
27 | TSSK6 | 1.71538317 |
28 | CDC7 | 1.71116559 |
29 | PLK3 | 1.68974206 |
30 | IRAK1 | 1.66105690 |
31 | IRAK2 | 1.66099635 |
32 | EPHA3 | 1.61961301 |
33 | PKN1 | 1.60632455 |
34 | MAP3K10 | 1.60526874 |
35 | EIF2AK3 | 1.57842200 |
36 | BMPR2 | 1.57426239 |
37 | NEK1 | 1.56669032 |
38 | MAP3K13 | 1.48225076 |
39 | TAOK3 | 1.46807911 |
40 | GRK5 | 1.46638796 |
41 | BMPR1B | 1.43648416 |
42 | STK39 | 1.40454194 |
43 | PIK3CG | 1.39458343 |
44 | KIT | 1.39326015 |
45 | CLK1 | 1.38079228 |
46 | WNK3 | 1.35053358 |
47 | PAK4 | 1.31706398 |
48 | FES | 1.29853428 |
49 | IKBKE | 1.28261125 |
50 | MST4 | 1.27154002 |
51 | WEE1 | 1.26949882 |
52 | MAP3K12 | 1.23329130 |
53 | OXSR1 | 1.23005705 |
54 | LRRK2 | 1.22643321 |
55 | YES1 | 1.20763856 |
56 | GRK1 | 1.19945277 |
57 | PIK3CA | 1.19325662 |
58 | CHEK2 | 1.19238951 |
59 | MAP3K3 | 1.16879874 |
60 | MYLK | 1.15384049 |
61 | TXK | 1.13020751 |
62 | MAP2K7 | 1.12300102 |
63 | BRSK2 | 1.10239570 |
64 | NUAK1 | 1.09492355 |
65 | MAPKAPK5 | 1.08343545 |
66 | NME1 | 1.05543272 |
67 | TBK1 | 1.04154721 |
68 | CDK19 | 1.01797530 |
69 | ABL2 | 0.99597897 |
70 | PLK1 | 0.98849153 |
71 | BCKDK | 0.98516935 |
72 | LMTK2 | 0.97853904 |
73 | IKBKB | 0.96523335 |
74 | EIF2AK2 | 0.96011253 |
75 | TYK2 | 0.95189037 |
76 | JAK1 | 0.94713218 |
77 | VRK1 | 0.94567033 |
78 | AURKA | 0.91746806 |
79 | MAPK13 | 0.91460302 |
80 | MET | 0.89935491 |
81 | PRKCE | 0.89911971 |
82 | DMPK | 0.89151889 |
83 | SIK3 | 0.88718976 |
84 | PLK4 | 0.88474903 |
85 | PRKCQ | 0.87782407 |
86 | TIE1 | 0.87565485 |
87 | OBSCN | 0.86963646 |
88 | BCR | 0.86735295 |
89 | TEC | 0.86289898 |
90 | EPHB1 | 0.84616580 |
91 | EPHA2 | 0.83536439 |
92 | STK3 | 0.83399953 |
93 | TAOK1 | 0.79934401 |
94 | CDK7 | 0.79665720 |
95 | FGFR1 | 0.78911280 |
96 | JAK3 | 0.77543968 |
97 | PRPF4B | 0.75888381 |
98 | ERBB4 | 0.74582535 |
99 | CAMK2A | 0.74327838 |
100 | MAP3K8 | 0.72619166 |
101 | CDK3 | 0.71884890 |
102 | NLK | 0.71401858 |
103 | TRIM28 | 0.71249045 |
104 | DYRK2 | 0.70420675 |
105 | PASK | 0.70397608 |
106 | PHKG2 | 0.68516023 |
107 | PHKG1 | 0.68516023 |
108 | CAMK2B | 0.68439303 |
109 | CDK8 | 0.68212956 |
110 | CHEK1 | 0.67480168 |
111 | LYN | 0.67355679 |
112 | NTRK3 | 0.67314552 |
113 | ILK | 0.67312007 |
114 | PDGFRA | 0.66705662 |
115 | CAMK2D | 0.66538915 |
116 | AURKB | 0.66119757 |
117 | PRKAA2 | 0.66088801 |
118 | NEK6 | 0.65990259 |
119 | SYK | 0.65456939 |
120 | MAPK12 | 0.64239363 |
121 | LCK | 0.64040784 |
122 | TRPM7 | 0.62636797 |
123 | STK38L | 0.61340156 |
124 | MST1R | 0.59964736 |
125 | EPHA4 | 0.59909288 |
126 | CAMK2G | 0.58637961 |
127 | FGR | 0.57700379 |
128 | FGFR4 | 0.57357778 |
129 | FGFR2 | 0.57153302 |
130 | MAP2K4 | 0.56493495 |
131 | CSNK2A1 | 0.55022232 |
132 | TLK1 | 0.54441008 |
133 | ADRBK1 | 0.54431005 |
134 | BRSK1 | 0.54344774 |
135 | PAK1 | 0.53903743 |
136 | NEK2 | 0.52075948 |
137 | CAMK1G | 0.51854118 |
138 | FLT3 | 0.51791111 |
139 | MKNK2 | 0.51618066 |
140 | CSNK2A2 | 0.51346939 |
141 | RAF1 | 0.51098319 |
142 | MAP2K3 | 0.51056888 |
143 | LATS2 | 0.50370593 |
144 | STK24 | 0.50253192 |
145 | PRKG1 | 0.50145988 |
146 | SIK2 | 0.50143650 |
147 | PRKACA | 0.48318221 |
148 | SGK2 | 0.48156601 |
149 | CDK4 | 0.48056276 |
150 | TNK2 | 0.47532071 |
151 | CAMKK2 | 0.47483737 |
152 | MKNK1 | 0.47438816 |
153 | MAPK4 | 0.46002202 |
154 | SGK223 | 0.45677588 |
155 | SGK494 | 0.45677588 |
156 | WNK4 | 0.45151396 |
157 | PAK2 | 0.44475190 |
158 | PNCK | 0.43500745 |
159 | BTK | 0.42471615 |
160 | NTRK1 | 0.41247206 |
161 | RPS6KA5 | 0.40341978 |
162 | HCK | 0.40097622 |
163 | CSF1R | 0.39980748 |
164 | CSNK1G3 | 0.39947018 |
165 | PIM2 | 0.39867221 |
166 | FER | 0.39806647 |
167 | ACVR1B | 0.38999556 |
168 | LATS1 | 0.38277681 |
169 | TAF1 | 0.38104332 |
170 | ATM | 0.38080373 |
171 | DDR2 | 0.37905453 |
172 | CSNK1G1 | 0.35224624 |
173 | ATR | 0.33566283 |
174 | ARAF | 0.32628659 |
175 | TGFBR1 | 0.32207846 |
176 | CSNK1E | 0.31084910 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.33868360 |
2 | Ribosome_Homo sapiens_hsa03010 | 3.63469850 |
3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.84943570 |
4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.80540555 |
5 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.77061232 |
6 | RNA polymerase_Homo sapiens_hsa03020 | 2.57469221 |
7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.56285291 |
8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.51202668 |
9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.41869355 |
10 | DNA replication_Homo sapiens_hsa03030 | 2.35839285 |
11 | Mismatch repair_Homo sapiens_hsa03430 | 2.33311982 |
12 | Basal transcription factors_Homo sapiens_hsa03022 | 2.25454851 |
13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.20214657 |
14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.10750640 |
15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.96343371 |
16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.94773763 |
17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92005620 |
18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.89917450 |
19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.88018946 |
20 | Allograft rejection_Homo sapiens_hsa05330 | 1.84676316 |
21 | Peroxisome_Homo sapiens_hsa04146 | 1.84530529 |
22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.79831178 |
23 | RNA transport_Homo sapiens_hsa03013 | 1.79004305 |
24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.76162657 |
25 | Nicotine addiction_Homo sapiens_hsa05033 | 1.72333571 |
26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70496351 |
27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.70314251 |
28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69214459 |
29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.67928095 |
30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.65469844 |
31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.60079447 |
32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.56743595 |
33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55888234 |
34 | Cell cycle_Homo sapiens_hsa04110 | 1.55792574 |
35 | Spliceosome_Homo sapiens_hsa03040 | 1.55572157 |
36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.53970798 |
37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.53272278 |
38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.50724461 |
39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.50237932 |
40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.48086760 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.47514923 |
42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.47021397 |
43 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.44859588 |
44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40924696 |
45 | Protein export_Homo sapiens_hsa03060 | 1.40830776 |
46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.38263095 |
47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36490398 |
48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35965417 |
49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35336892 |
50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.34355936 |
51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.32829699 |
52 | Retinol metabolism_Homo sapiens_hsa00830 | 1.32493366 |
53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32318733 |
54 | Homologous recombination_Homo sapiens_hsa03440 | 1.31920102 |
55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.28994143 |
56 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.28918933 |
57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26454560 |
58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.25668303 |
59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.23749561 |
60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22967454 |
61 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.21461967 |
62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21359763 |
63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.20447984 |
64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.19498966 |
65 | Base excision repair_Homo sapiens_hsa03410 | 1.17890642 |
66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17272929 |
67 | ABC transporters_Homo sapiens_hsa02010 | 1.16519547 |
68 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16406372 |
69 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.14100643 |
70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.13877647 |
71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.12570790 |
72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11683645 |
73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09541250 |
74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.08008223 |
75 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.05953082 |
76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05072975 |
77 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01612443 |
78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01177461 |
79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00671723 |
80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00215303 |
81 | RNA degradation_Homo sapiens_hsa03018 | 0.99944134 |
82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97539577 |
83 | Malaria_Homo sapiens_hsa05144 | 0.96217911 |
84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.94930337 |
85 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.94674716 |
86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94541219 |
87 | Asthma_Homo sapiens_hsa05310 | 0.93419116 |
88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.93110303 |
89 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.92526560 |
90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92041107 |
91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.92039885 |
92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91699647 |
93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91668214 |
94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88502262 |
95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88442909 |
96 | Purine metabolism_Homo sapiens_hsa00230 | 0.87304064 |
97 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87025668 |
98 | Phototransduction_Homo sapiens_hsa04744 | 0.85158614 |
99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85044671 |
100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82917592 |
101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.82523581 |
102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81333784 |
103 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80958041 |
104 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79413033 |
105 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79245572 |
106 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.78789931 |
107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77440780 |
108 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76719320 |
109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74349930 |
110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73402311 |
111 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73278053 |
112 | Morphine addiction_Homo sapiens_hsa05032 | 0.70675935 |
113 | Measles_Homo sapiens_hsa05162 | 0.70060883 |
114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.69066892 |
115 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68105384 |
116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67884599 |
117 | Mineral absorption_Homo sapiens_hsa04978 | 0.67323120 |
118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65753423 |
119 | Lysine degradation_Homo sapiens_hsa00310 | 0.65312395 |
120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65139990 |
121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64876733 |
122 | Taste transduction_Homo sapiens_hsa04742 | 0.63794750 |
123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62949443 |
124 | Phagosome_Homo sapiens_hsa04145 | 0.61691289 |
125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61395424 |
126 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.61290652 |
127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60530050 |
128 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59778905 |
129 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59464198 |
130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57311947 |
131 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56938646 |
132 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.54159915 |
133 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52515201 |
134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52178303 |
135 | Pertussis_Homo sapiens_hsa05133 | 0.52042799 |
136 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51731714 |
137 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51706546 |
138 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50906648 |
139 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49590404 |
140 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.48526132 |
141 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48367953 |
142 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47063073 |
143 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46732071 |
144 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46325247 |
145 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46242702 |
146 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45357515 |
147 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44818362 |
148 | Adherens junction_Homo sapiens_hsa04520 | 0.44274752 |
149 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44185174 |
150 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44081265 |
151 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41133941 |
152 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39972442 |
153 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39067099 |
154 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37726141 |
155 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37227621 |
156 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.34641041 |
157 | Axon guidance_Homo sapiens_hsa04360 | 0.28845706 |